<DOC>
	<DOCNO>NCT00195520</DOCNO>
	<brief_summary>To evaluate tolerability , bleed pattern acceptability Totelle® 1mg administer population Brazilian woman continuous combine regime hormone replacement therapy .</brief_summary>
	<brief_title>Study Evaluating Totelle® Menopausal Symptoms Sexual Function</brief_title>
	<detailed_description />
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<criteria>Intact uterus Generally health postmenopausal woman 45 60 year age , inclusive Sexually active No hormone replacement therapy within 90 day immediately prior screen evaluation . Known suspect estrogendependent neoplasia Known hypersensitivity estrogen , progestin , ingredient Totelle Use estrogen , progestin , androgen contain medication tibolone within 12 week screen .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Menopause</keyword>
	<keyword>Sleep Disorder</keyword>
	<keyword>Hot Flashes</keyword>
</DOC>